1
|
Vecchia M, Sacchi P, Marvulli LN, Ragazzoni L, Muzzi A, Polo L, Bruno R, Salio F. Healthcare Application of Failure Mode and Effect Analysis (FMEA): Is There Room in the Infectious Disease Setting? A Scoping Review. Healthcare (Basel) 2025; 13:82. [PMID: 39791689 PMCID: PMC11719677 DOI: 10.3390/healthcare13010082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2024] [Revised: 12/28/2024] [Accepted: 12/30/2024] [Indexed: 01/12/2025] Open
Abstract
Background: Failure mode and effect analysis (FMEA) is a valuable risk analysis tool aimed at predicting the potential failures of a system and preventing them from occurring. Since its initial use, it has also recently been applied to the healthcare setting, which has been made progressively more complex by technological developments and new challenges. Infection prevention and control (IPC) is an area that requires effective strategies. The aim of this study is to review the literature on the employment of FMEA in the healthcare environment, with special consideration for its application in the infectious disease setting. Methods: An extensive search was carried out in two international and public databases, PUBMED and EMBASE; we included all studies regarding the use of FMEA in hospital settings and human patient care processes. Results: A total of 163 studies published over the period from 2003 to 2023 were included for data extraction. These studies were analyzed regarding bibliometric data (publication year and country of origin), the healthcare issues to be addressed, the application fields, and the utilized FMEA methods. Among these, 13 studies were found that took an interest in infectious diseases. Conclusions: FMEA can be effectively used for healthcare risk assessment. Its implementation as a standard tool in healthcare settings, though demanding, may serve as an important tool for preventing the risk of biohazard incidents, epidemics, and environmental contamination, thereby improving safety for both patients and healthcare workers.
Collapse
Affiliation(s)
- Marco Vecchia
- Division of Infectious Diseases Unit I, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; (P.S.); (L.N.M.); (R.B.)
| | - Paolo Sacchi
- Division of Infectious Diseases Unit I, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; (P.S.); (L.N.M.); (R.B.)
| | - Lea Nadia Marvulli
- Division of Infectious Diseases Unit I, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; (P.S.); (L.N.M.); (R.B.)
| | - Luca Ragazzoni
- CRIMEDIM—Center for Research and Training in Disaster Medicine, Humanitarian Aid and Global Health, Università del Piemonte Orientale, 28100 Novara, Italy;
| | - Alba Muzzi
- Medical Direction, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy;
| | - Lorenzo Polo
- Department of Quality and Risk Management, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy;
| | - Raffaele Bruno
- Division of Infectious Diseases Unit I, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy; (P.S.); (L.N.M.); (R.B.)
- Department of Clinical Surgical Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy
| | - Flavio Salio
- Emergency Medical Teams, Country Readiness Strengthening Department, World Health Organization, 1211 Geneva, Switzerland;
| |
Collapse
|
2
|
Martínez CS, Amery L, De Paoli G, Elofsson U, Fureby AM, Kwok S, López-Cabezas C, Rosenberger M, Schoenau C, Wahlgren M, Paulsson M. Examination of the Protein Drug Supply Chain in a Swedish University Hospital: Focus on Handling Risks and Mitigation Measures. J Pharm Sci 2023; 112:2799-2810. [PMID: 37160226 DOI: 10.1016/j.xphs.2023.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Revised: 05/01/2023] [Accepted: 05/01/2023] [Indexed: 05/11/2023]
Abstract
Protein drugs, such as monoclonal antibodies, have proved successful in treating cancer and immune system diseases. The structural complexity of these molecules requires careful handling to ensure integrity and stability of the drug. In this study, a failure mode and effects analysis was performed based on a Gemba Walk method in a Swedish University Hospital. The Gemba Walk is focused on pharmacists observing the actual supply process steps from distributor, pharmacy cleanroom to patient administration. Relevant protein drugs are chosen based on sales statistics within the hospital and the corresponding wards were observed. Further is the Double Diamond design method used to identify major risks and deliver mitigation strategies. The study identified potential stress factors such as temperature, shock by impact, shaking, vibration and light exposure. There were also risks associated with porters' and healthcare professionals' lack of awareness and access to information. These risk factors may cause loss of efficacy and quality of the protein drug, potentially leading to patient safety concerns. In this study, a simulation is also performed to list measures that theoretically should be in place to ensure the quality of the protein drug, for example validated and protocol-based compounding in cleanroom, training and validated transports.
Collapse
Affiliation(s)
- Clàudia Sabaté Martínez
- Department of Women's and Children's Health, Uppsala University, Akademiska sjukhuset, SE-751 85 Uppsala, Sweden; Faculty of Pharmacy and Food Science, University of Barcelona, Spain
| | - Leanne Amery
- Late Stage Formulation Sciences, BioPharmaceuticals Development, Dosage Form Design & Development, AstraZeneca, Granta Park, Cambridge, UK
| | - Giorgia De Paoli
- MEMO Research, Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK
| | - Ulla Elofsson
- RISE Research Institute of Sweden, Stockholm, Sweden
| | | | - Stanley Kwok
- Late Stage Formulation Sciences, BioPharmaceuticals Development, Dosage Form Design & Development, AstraZeneca, One MedImmune Way, Gaithersburg, MD 20878, USA
| | | | - Marika Rosenberger
- Sanofi-Aventis Deutschland GmbH, Biologics Drug Product Development & Manufacturing, Industriepark Hoechst, K703. Brüningstr. 50, 65926 Frankfurt am Main, Germany
| | - Christian Schoenau
- Sanofi-Aventis Deutschland GmbH, Biologics Drug Product Development & Manufacturing, Industriepark Hoechst, K703. Brüningstr. 50, 65926 Frankfurt am Main, Germany
| | - Marie Wahlgren
- Department of Food Technology, Lund University, P.O. Box 124, 22100 Lund, Sweden
| | - Mattias Paulsson
- Department of Women's and Children's Health, Uppsala University, Akademiska sjukhuset, SE-751 85 Uppsala, Sweden.
| |
Collapse
|
3
|
Ullah E, Baig MM, GholamHosseini H, Lu J. Failure mode and effect analysis (FMEA) to identify and mitigate failures in a hospital rapid response system (RRS). Heliyon 2022; 8:e08944. [PMID: 35243066 PMCID: PMC8857483 DOI: 10.1016/j.heliyon.2022.e08944] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 02/05/2022] [Accepted: 02/09/2022] [Indexed: 11/18/2022] Open
Abstract
We performed FMEA on the existing RRS with the help of routine users of the RRS who acted as subject matter experts and evaluated the failures for their criticality using the Risk Priority Number approach based on their experience of the RRS. The FMEA found 35 potential failure modes and 101 failure mode effects across 13 process steps of the RRS. The afferent limb of RRS was found to be more prone to these failures (62, 61.4%) than the efferent limb of the RRS (39, 38.6%). Modification of calling criteria (12, 11.9%) and calculation of New Zealand Early Warning Scores (NZEWS) calculation (11, 10.9%) steps were found to potentially give rise to the highest number of these failures. Causes of these failures include human error and related factors (35, 34.7%), staff workload/staffing levels (30, 29.7%) and limitations due to paper-based charts and organisational factors (n = 30, 29.7%). The demonstrated electronic system was found to potentially eliminate or reduce the likelihood of 71 (70.2%) failures. The failures not eliminated by the electronic RRS require targeted corrective measures including scenario-based training and education, and revised calling criteria to include triggers for hypothermia and high systolic blood pressure.
Collapse
Affiliation(s)
- Ehsan Ullah
- School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
- Clinical Governance Support Unit, Taranaki District Health Board, Private Bag Private Bag 2016, New Plymouth 4342, New Zealand
| | - Mirza Mansoor Baig
- School of Engineering, Computer and Mathematical Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
| | - Hamid GholamHosseini
- School of Engineering, Computer and Mathematical Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
| | - Jun Lu
- School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Private Bag 92006, Auckland 1142, New Zealand
- School of Public Health and Interdisciplinary Studies, Faculty of Health and Environmental Sciences, Auckland University of Technology, New Zealand
- Maurice Wilkins Centre for Molecular Discovery, Auckland 1010, New Zealand
- College of Food Science and Technology, Nanchang University, Nanchang 330031, Jiangxi Province, China
- College of Food Engineering and Nutrition Sciences, Shaanxi Normal University, Xi'an 710119, Shaanxi Province, China
- Corresponding author.
| |
Collapse
|
4
|
Liu HC, Zhang LJ, Ping YJ, Wang L. Failure mode and effects analysis for proactive healthcare risk evaluation: A systematic literature review. J Eval Clin Pract 2020; 26:1320-1337. [PMID: 31849153 DOI: 10.1111/jep.13317] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/05/2019] [Revised: 10/08/2019] [Accepted: 10/28/2019] [Indexed: 12/23/2022]
Abstract
RATIONALE, AIMS, AND OBJECTIVES Failure mode and effects analysis (FMEA) is a valuable reliability management tool that can preemptively identify the potential failures of a system and assess their causes and effects, thereby preventing them from occurring. The use of FMEA in the healthcare setting has become increasingly popular over the last decade, being applied to a multitude of different areas. The objective of this study is to review comprehensively the literature regarding the application of FMEA for healthcare risk analysis. METHODS An extensive search was carried out in the scholarly databases of Scopus and PubMed, and we only chose the academic articles which used the FMEA technique to solve healthcare risk analysis problems. Furthermore, a bibliometric analysis was performed based on the number of citations, publication year, appeared journals, authors, and country of origin. RESULTS A total of 158 journal papers published over the period of 1998 to 2018 were extracted and reviewed. These publications were classified into four categories (ie, healthcare process, hospital management, hospital informatization, and medical equipment and production) according to the healthcare issues to be solved, and analyzed regarding the application fields and the utilized FMEA methods. CONCLUSION FMEA has high practicality for healthcare quality improvement and error reduction and has been prevalently employed to improve healthcare processes in hospitals. This research supports academics and practitioners in effectively adopting the FMEA tool to proactively reduce healthcare risks and increase patient safety, and provides an insight into its state-of-the-art.
Collapse
Affiliation(s)
- Hu-Chen Liu
- School of Economics and Management, Tongji University, Shanghai, People's Republic of China.,College of Economics and Management, China Jiliang University, Hangzhou, People'sRepublic of China
| | - Li-Jun Zhang
- School of Management, Shanghai University, Shanghai, People's Republic of China
| | - Ye-Jia Ping
- School of Management, Shanghai University, Shanghai, People's Republic of China
| | - Liang Wang
- School of Management, Shanghai University, Shanghai, People's Republic of China
| |
Collapse
|
5
|
Alban RF, Anania EC, Cohen TN, Fabri PJ, Gewertz BL, Jain M, Jopling JK, Maggio PM, Sanchez JA, Sax HC. Performance improvement in surgery. Curr Probl Surg 2019; 56:211-246. [PMID: 31155033 DOI: 10.1067/j.cpsurg.2019.02.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2019] [Accepted: 02/06/2019] [Indexed: 12/30/2022]
Affiliation(s)
- Rodrigo F Alban
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
| | | | - Tara N Cohen
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
| | | | - Bruce L Gewertz
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
| | - Monica Jain
- University of California San Francisco Medical Center, San Francisco, CA
| | | | | | - Juan A Sanchez
- St. Agnes Hospital, Johns Hopkins University School of Medicine, Baltimore, MD
| | - Harry C Sax
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA.
| |
Collapse
|